abstract |
Compounds of formula (I): wherein Ri, R2, R3, B, W, Z, m and n are as defined in the description. The compounds of the present invention have pro-apoptotic and/or anti-proliferative properties making it possible to use them in pathologies involving a defect in apoptosis, such as, for example, in the treatment of cancer and of immune and auto-immune diseases. )7 |